BioSurfaces, a US-based company that deals with advanced nanofiber materials, along with Morphocell Technologies, a Canada-based regenerative medicine company, announced on Friday a collaboration aimed at exploring the potential of BioSurfaces' proprietary Bio-Spun material for therapeutic applications.

With a focus on leveraging Bio-Spun's unique properties to advance innovations in regenerative medicine, the partnership will combine BioSurfaces' expertise in biomaterials with Morphocell's knowledge of cell-based therapies. The companies say that they seek to develop new solutions that address critical healthcare challenges.

The partnership is to concentrate on early-stage research efforts to assess Bio-Spun in various therapeutic applications, with the long-term vision of contributing to the progress of regenerative treatments for patients globally.